References
- Chien Y. W. Novel Drug Delivery Systems”, 2nd edition. Dekker, New York 1992, Chapters 3, 4 & 7.
- Palmer K. J., Buckley M. M., Faulds D. Drugs 1992; 44: 498
- Surgeon General. Reducing the Health Consequences of Smoking. U.S. Department of Health and Human Services, Washington, DC 1989
- Glantz S. A., Parmley W. W. Circulation 1991; 83: 1
- Gilman A. G., Rail T. W., Nies A. S., Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics”, 8th edition. Pergamon Press, New York 1990
- Willett W. C., Green A., Stampfer M. J., Speizer F. E., Colditz G. A., Rosner B., Monson R. R., Stason W., Hennekens C. H. N. Engl. J. Med. 1987; 317: 1303
- Benowitz N. L. Ann. Rev. Med. 1986; 37: 21
- Benowitz N. L. N. Engl. J. Med. 1988; 319: 1318
- Turner D. M., Armitage A. K., Briant R. H., Dollery C. T. Xenobiotica 1975; 5: 539
- Surgeon General. The Health Consequences of Smoking-Nicotine Addiction. U.S. Department of Health and Human Services, Washington, DC 1988
- Fagerstrom K. O. Int'l. Rev. Appl. Psychol. 1983; 32: 29
- West R. J. J. Psychosom. Res. 1984; 28: 379
- Franke F. E., Thomas J. E. Proc. Soc. Expt. Biol. Med. 1932; 29: 117
- Armitage A. K., Turner D. M. Nature 1970; 226: 1231
- Wald N. J., Idle M., Borcham J., Bailey A. Lancet 1981; 2: 775
- Beckett A. H., Garrod J. W., Jenner P. J. Pharm. Pharmacol. 1972; 24: 115
- Schievelbein H. Pharmacol. Therap. 1982; 18: 233
- Squier C. A. J. Appl. Toxicol. 1986; 6: 123
- Temple D. J. Arch. Pharmacol 1976; 309: 984
- Russell M. A.H., Jarvis M. J., De Vitt G., Feyerabend C. Br. Med. J. 1981; 283: 814
- Collins P., Laffoon J., Squier C. A. J. Dent. Res. 1981; 60: 933
- Gritz E. R., Baer V. Weiss, Benowitz N. L., Van Vunatis H., Jarvi M. E. Clin. Pharmacol. Therap. 1981; 30: 201
- Gourlay S. G., Mc Neil J. J. Med. J. Australia 1990; 153: 699
- Benowitz N. L., Porchet H., Sheiner L. P., Jacob I II. Clin. Pharmacol. Therap. 1988; 44: 23
- Physician's Desk Reference, 46th edition. Medical Economics Data, Montvale, New Jersey 1992; 1335
- Buchkremer G., Bents H., Horstmann M., Optiz K., Tolle R. Addictive Behaviors 1989; 14: 229
- Henningfield J. E., Radzins A., Cooper T. M., Clayton R. R. J. Am. Med. Assoc. 1990; 264: 1560
- Hughes J. R., Hatsukami D. K., Skoog K. P. J. Am. Med. Assoc. 1986; 255: 3277
- Lam W., Sze P. C., Sacks H. S., Chalmers T. C. Lancet 1987; 2: 27
- Abelin T., Buehler A., Müller P., Vesanen K., Imhof P. R. Lancet 1989; 1: 7–10
- Transdermal Nicotine Study Group. J. Am. Med. Assoc. 1991; 266: 3133
- Kochak G. M., Sun J. X., Choi R. L., Piraino A. J. Pharm. Research 1992; 9: 1451
- Benowitz N. L. British J. of Addiction 1991; 86: 495–499
- Chien Y. W., Keshary P. K., Huang Y. C., Sarpotdar P. P. J. Pharm. Sci. 1983; 22: 968
- Ho H., Chien Y. W. Drug Develop. Ind. Pharm. 1993; 19: 295
- Nicoderm® (nicotine transdermal system) product information. Marion Merrell Dow. 1991
- Habitrol® (nicotine transdermal system) product information. CibaGeigy. 1992
- Prostep® (nicotine transdermal system) product information. Lederle. 1992
- Nicotrol® (nicotine transdermal system) product information. Parke-Davis. 1992
- United States Patent application (pending)
- Lin S. S., Ho H., Chien Y. W. J. Control. Release 1993
- Lane J. D., Westman E. C., Ripta G. V., Wu J., Chiang C. C., Rose J. E. Drug Develop. Ind. Pharm. 1993; 19: 1999
- Lin H. N., Hsu T. M., Jiang T. S., Chen R. C. Int'l. Symp. Biomedical Engineering In the 21st Century, TaipeiTaiwan, September, 23–261992, 148, Program and Abstract Book
- Lin S. S., Chien Y. W.W., Huang C. C., Li H. C., Chueh L. R.R., Chen L. T., Hsu M. T., Jiang S., Wu J., Valia K. H. Drug Develop. Ind. Pharm. 1993; 19
- Redding T. W., Schally A. V. Neuroendocrinology 1972; 9: 250
- Okada H., Yamazaki I., Ogawa Y., Hirai S., Yashiki T., Mima H. J. Pharm. Sci. 1982; 71: 1367
- Hageman M. J. Drug Develop. Ind. Pharm. 1988; 14: 2047
- Docherty K., Carroll R., Steiner D. F. Proc. Nat'l. Acad. Sci. (USA) 1982; 79: 4613
- Emdin S. O., Dodson G. G., Cutfield J. M., Cutfield S. M. Diabetologia 1974; 19: 174
- Given B., Cohen R., Brank B., Rubenstein A., Tager H. Clin. Res. 1985; 31: 569A
- Brownstein M. J. Proc. Royal Soc. (Lond. B). 1980; 210: 79
- Nicholl R. A., Alger B. E., Jahr C. E. Proc. Royal Soc. Lond. Biol. 1980; 210: 133
- Weinberger S. B., Martinez J. L. J. Pharmacol. Exp. Ther. 1988; 247: 129
- Vogel Z., Miron T., Altstein M., Wilchek M. Biochem. Biophys. Res. Commun. 1978; 85: 226
- Hambrook J. M., Morgan B. A., Rance M. J., Smith L. F.C. Nature 1976; 262: 782
- Graf L., Nagy A., Lajtha A. Life Sci. 1982; 31: 1861
- van Amsterdam J. G. C., van Buuren K. J.H., de Jongm A., Soudijn W. Life Sci. 1983; 33(suppl. I)109
- Hersh L. B., Mc Kelvy J. F. J. Neurochem. 1981; 36: 171
- Marks N., Grynbaum A., Neidle A. Biochem. Biophys. Res. Commun. 1977; 24: 1552
- Gillespie M. N., Krechniak J. W., Crooks P. A., Altiere R. J., Olson J. W. J. Pharmacol. Exp. Then 1985; 232: 675
- Cohen M. L., Geary L. E., Wiley K. S. J. Pharmacol. Exp. Ther. 1983; 224: 379
- Choi H. K., Flynn G. L., Amidon G. L. Pharm. Res. 1990; 7: 1099
- Dodda Kashi S., Lee V. H.L. Life Sci. 1986; 28: 2019
- Dodda Kashi S., Lee V. H.L. Invest. Ophthalmol. Vis. Sci. 1986; 27: 1300
- Lee V. H.L. Pharm. Technol. April 26, 1987
- Garen K. W., Repta A. J. Int'l. J. Pharm. 1988; 48: 189
- Chun I. K., Chien Y. W. J. Pharm. Sci. 1993; 82: 373
- Sayani A. P., Chun I. K., Chien Y. W. J. Pharm. Sci. 1993; 82
- Rich D. H., Moon B. J., Harbeson S. J. Med. Chem. 1984; 27: 417
- Chun I. K., Chien Y. W., unpublished data
- Shah P. K., Borchardt R. T. Pharm. Res. 1989; 6: S148
- Chien Y. W. Systemic delivery of therapeutic peptides: Overcome of enzymatic barrier and enhancement of permeation. Second Jerusalem Conference on Pharmaceutical Sciences and Clinical Pharmacology, JerusalemIsrael, May, 24–291992